Table 1

Patient characteristics

VariableCulprit lesions in UAPp ValueNon-culprit lesions in UAPp ValueLesions in SAPp Value
NV (n=32)No NV (n=60)NV (n=70)No NV (n=133)NV (n=17)No NV (n=44)
Men, n (%)25 (78)42 (70)0.4052 (74)89 (67)0.2810 (59)29 (66)0.61
Age, years57±1158±80.6659±858±90.3954±755±80.44
Smoker, n (%)18 (56)30 (50)0.5747 (67)66 (50)0.028 (47)16 (36)0.44
Hypertension, n (%)19 (59)31 (52)0.4843 (61)70 (53)0.2312 (71)25 (57)0.32
Dyslipidaemia, n (%)17 (53)35 (58)0.6332 (45)69 (52)0.409 (53)23 (52)0.96
Diabetes, n (%)9 (28)20 (33)0.6134 (49)54 (41)0.287 (41)14 (32)0.49
Family history7 (22)19 (32)0.3220 (29)35 (26)0.735 (29)15 (34)0.73
Medications
 Aspirin, n (%)31 (97)59 (98)1.0068 (97)131 (99)0.6116 (94)37 (84)0.54
 Clopidogrel, n (%)28 (88)53 (88)1.0065 (93)125 (94)0.9912 (71)35 (80)0.68
 Statin, n (%)31 (97)53 (88)0.3260 (86)113 (85)0.8715 (88)42 (96)0.31
 ACEI or ARB, n (%)18 (56)28 (47)0.3836 (51)62 (47)0.519 (53%)20 (46)0.60
  • Data are presented as mean ±SD, n (%).

  • ACEI, ACE inhibitor; ARB, angiotensin II receptor blockers; NV, neovascularisation; SAP, stable angina pectoris; UAP, unstable angina pectoris; SAP, stable angina pectoris.